Syntax Research’s Lexicon Pharmaceuticals LXRX Stock Holding History

Syntax Research’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$222	Hold	142	–	–	﹤0.01%	173
2025 Q4	$164	Hold	142	–	–	﹤0.01%	172
2025 Q3	$192	Hold	142	–	–	﹤0.01%	172
2025 Q2	$135	Hold	142	–	–	﹤0.01%	170
2025 Q1	$66	Hold	142	–	–	﹤0.01%	175
2024 Q4	$105	Hold	142	–	–	﹤0.01%	183
2024 Q3	$223	Hold	142	–	–	﹤0.01%	190
2024 Q2	$239	Hold	142	–	–	﹤0.01%	174
2024 Q1	$341	Hold	142	–	–	﹤0.01%	168
2023 Q4	$218	Hold	142	–	–	﹤0.01%	175
2023 Q3	$155	Buy	+142	New	+$249	﹤0.01%	178

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return